Newsroom

CARLSBAD, Calif.--(BUSINESS WIRE)--Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) today announced the appointment of Ludwig Hantson, Ph.D., an accomplished global biopharmaceutical leader, to the Ionis Board of Directors, effective immediately.“We are pleased to welcome Dr. Hantson to the board,” said Joseph Loscalzo, M.D., Ph.D., chairman of the Ionis Board of Directors. “Ludwig’s biopharma executive leadership experience will be especially meaningful as Ionis prepares for a steady cadence of new c...

DUBAI, United Arab Emirates--(BUSINESS WIRE)--AIR Highlights Key Financial Details Following Nasdaq Listing...

TULSA, Okla.--(BUSINESS WIRE)--Alliance Resource Partners, L.P. Expands Oil & Gas Royalties Platform With $206 Million Acquisition...

NEW YORK--(BUSINESS WIRE)--TWO Challenges UWMC to Submit All-Cash Offer With No Stock Component...

MINNEAPOLIS--(BUSINESS WIRE)--In partnership with Meta, Best Buy is bringing Meta Lab @ Best Buy to more than 50 of its stores this summer. These 900-square-foot experiential spaces give customers a hands-on way to explore Meta’s full product lineup of AI glasses and VR headsets through interactive demos and displays, smart mirrors, personalized fittings and more. Meta AI Glasses are designed to be worn and explored firsthand. Customers want to know the fit, feel and experience, which is where...

SALT LAKE CITY & TEL AVIV, Israel--(BUSINESS WIRE)--Palladyne AI and IAI Form Partnership to Manufacture and Sell Combat-Proven Loitering Munition Systems to the U.S. Department of War...

CHICAGO--(BUSINESS WIRE)--NielsenIQ (NYSE: NIQ), a global leader in consumer intelligence, today announced a new Global Data Synchronization Network (GDSN) capability within NIQ Product Intelligence, extending the ability to create, govern, and activate a single product record across supply chains, digital commerce, and enabling AI-powered shopping environments. The capability is designed to move GDSN participation beyond basic compliance and into measurable business performance at scale. Built...

WILMINGTON, Del.--(BUSINESS WIRE)--Incyte to Acquire Vega Therapeutics, a Wholly Owned Subsidiary of Star Therapeutics, Expanding its Hematology Portfolio into Bleeding Disorders...

BATAVIA, N.Y.--(BUSINESS WIRE)--Graham Corporation (NYSE: GHM) (“GHM,” “Graham,” or the “Company”), a global leader in the design and manufacture of mission critical fluid, power, heat transfer, vacuum, and advanced mixing technologies for the Defense, Energy & Process, and Space industries, today reported financial results for the fourth quarter and fiscal year ended March 31, 2026 (“fiscal 2026”). Graham’s President and Chief Executive Officer, Matthew J. Malone stated, “Fiscal 2026 was a...

BOSTON--(BUSINESS WIRE)--Seaport Therapeutics Reports Positive Multiple-Ascending Dose Data from Phase 1 Proof-of-Concept Trial of GlyphAgo™ in Healthy Volunteers...